Mark E. Schmidt

7.4k citations

126 papers · 4.8k indexed · 1 hit paper · h-index 32

Impact in

Biological Psychiatry top 1%
Psychiatry and Mental health top 0.5%
- Dementia and Cognitive Impairment Research

Papers in ⓘ

Biological Psychiatry 9
Psychiatry and Mental health 44
- Dementia and Cognitive Impairment Research 19
- Bipolar Disorder and Treatment 11

Co-authors: William J. Jagust (6 shared papers)Holly Soares (5 shared papers)Leslie M. Shaw (3 shared papers)John Q. Trojanowski (3 shared papers)John C. Morris (3 shared papers)Clifford R. Jack (3 shared papers)Robert C. Green (3 shared papers)Andrew J. Saykin (3 shared papers)
Journals: Alzheimer s & Dementia (19 papers)Journal of Nuclear Medicine (8 papers)European Journal of Nuclear Medicine and Molecular Imaging (6 papers)Neuropsychopharmacology (5 papers)European Neuropsychopharmacology (5 papers)
Partner nations: United States Belgium United Kingdom

In The Last Decade

Mark E. Schmidt

122 papers receiving 4.7k citations

Hit Papers

align trajectories log scale

The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception 2013 · 698 citations

Peers

Countries citing papers authored by Mark E. Schmidt

Since Specialization

Citations

This map shows the geographic impact of Mark E. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Schmidt more than expected).

Fields of papers citing papers by Mark E. Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Schmidt. The network helps show where Mark E. Schmidt may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. Schmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. Schmidt Line = papers co-authored together Mark E. Schmidt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception Alzheimer s & Dementia ·Michael W. Weiner, Dallas P. Veitch, Paul Aisen, Laurel Beckett, Nigel J. Cairns, Robert C. Green, Danielle Harvey, Clifford R. Jack, William J. Jagust, Enchi Liu, John C. Morris, Ronald C. Petersen, Andrew J. Saykin, Mark E. Schmidt, Leslie M. Shaw, Li Shen, Judith A. Siuciak, Holly Soares, Arthur W. Toga, John Q. Trojanowski, (unknown) Hit paper breakdown →	2013	698
2	The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans Alzheimer s & Dementia ·Michael W. Weiner, Paul Aisen, Clifford R. Jack, William J. Jagust, John Q. Trojanowski, Leslie M. Shaw, Andrew J. Saykin, John C. Morris, Nigel J. Cairns, Laurel Beckett, Arthur W. Toga, Robert C. Green, Sarah Walter, Holly Soares, Peter J. Snyder, Eric Siemers, William Z. Potter, Patricia E. Cole, Mark E. Schmidt, (unknown)	2010	415
3	The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception Alzheimer s & Dementia ·Michael W. Weiner, Dallas P. Veitch, Paul Aisen, Laurel Beckett, Nigel J. Cairns, Robert C. Green, Danielle Harvey, Clifford R. Jack, William J. Jagust, Enchi Liu, John C. Morris, Ronald C. Petersen, Andrew J. Saykin, Mark E. Schmidt, Leslie M. Shaw, Judith A. Siuciak, Holly Soares, Arthur W. Toga, John Q. Trojanowski, (unknown)	2011	367
4	Reduced Reward Learning Predicts Outcome in Major Depressive Disorder Biological Psychiatry ·Elske Vrieze, Diego A. Pizzagalli, Koen Demyttenaere, Titia Hompes, Pascal Sienaert, Peter de Boer, Mark E. Schmidt, Stephan Claes	2012	313
5	Novel Radiotracers for Imaging the Serotonin Transporter by Positron Emission Tomography: Synthesis, Radiosynthesis, and in Vitro and ex Vivo Evaluation of ¹¹C-Labeled 2-(Phenylthio)araalkylamines Journal of Medicinal Chemistry ·Alan A. Wilson, Nathalie Ginovart, Mark E. Schmidt, Jeffery H. Meyer, Penny G. Threlkeld, Sylvain Houle	2000	217
6	Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Susan Landau, Benjamin A. Thomas, Lennart Thurfjell, Mark E. Schmidt, Richard Margolin, Mark A. Mintun, Michael J. Pontecorvo, Suzanne L. Baker, William J. Jagust	2014	202
7	Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688. PubMed ·Simon M. Ametamey, Valérie Treyer, Johannes Streffer, Matthias T. Wyss, Mark E. Schmidt, M. Blagoev, Samuel Hintermann, Yves P. Auberson, F. Gasparini, Uta C. Fischer, Alfred Buck	2007	136
8	Femtosecond spontaneous-emission studies of reaction centers from photosynthetic bacteria. Proceedings of the National Academy of Sciences ·Meirong Du, Sandra J. Rosenthal, Xiaona Xie, Theodore J. DiMagno, Mark E. Schmidt, Deborah K. Hanson, M. Schiffer, James R. Norris, Graham R. Fleming	1992	110
9	Dimensions in major depressive disorder and their relevance for treatment outcome Journal of Affective Disorders ·Elske Vrieze, Koen Demyttenaere, Ronny Bruffaerts, Dirk Hermans, Diego A. Pizzagalli, Pascal Sienaert, Titia Hompes, Peter de Boer, Mark E. Schmidt, Stephan Claes	2013	107
10	The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data Alzheimer s & Dementia ·Mark E. Schmidt, Ping Chiao, Gregory Klein, Dawn C. Matthews, Lennart Thurfjell, Patricia E. Cole, Richard Margolin, Susan Landau, Norman L. Foster, N. Scott Mason, Susan De Santi, Joyce Suhy, Robert A. Koeppe, William J. Jagust, (unknown)	2014	93
11	Size-dependent two-photon excitation spectroscopy of CdSe nanocrystals Physical review. B, Condensed matter ·Mark E. Schmidt, Sean A. Blanton, Margaret A. Hines, Philippe Guyot‐Sionnest	1996	79
12	Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathology Alzheimer s Research & Therapy ·Jelle Praet, Nikolay V. Manyakov, Leacky Muchene, Zhenhua Mai, Vasilis Terzopoulos, Steve De Backer, An Torremans, Pieter‐Jan Guns, Tom Van de Casteele, Astrid Bottelbergs, Bianca Van Broeck, Jan Sijbers, Dirk Smeets, Ziv Shkedy, Luc Bijnens, Darrel J. Pemberton, Mark E. Schmidt, Annemie Van der Linden, Marleen Verhoye	2018	76
13	Preclinical Evaluation of a P2X7 Receptor–Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates Journal of Nuclear Medicine ·Dieter Ory, Sofie Celen, Rik Gijsbers, Chris Van den Haute, Andrey Postnov, Michel Koole, Caroline Vandeputte, José-Ignacio Andrés, Jesús Alcázar, Meri De Angelis, Xavier Langlois, Anindya Bhattacharya, Mark E. Schmidt, Michael A. Letavic, Wim Vanduffel, Koen Van Laere, Alfons Verbruggen, Zeger Debyser, Guy Bormans	2016	75
14	The effects of inhibition of fatty acid amide hydrolase (FAAH) by JNJ-42165279 in social anxiety disorder: a double-blind, randomized, placebo-controlled proof-of-concept study Neuropsychopharmacology ·Mark E. Schmidt, Michael R. Liebowitz, Murray B. Stein, Jennifer Grunfeld, Ilse Van Hove, W. Kyle Simmons, Peter van der Ark, James A. Palmer, Ziad S. Saad, Darrel J. Pemberton, Luc Van Nueten, Wayne C. Drevets	2020	67
15	Urinary Free Cortisol Output and Disruptive Behavior in Children Journal of the American Academy of Child & Adolescent Psychiatry ·Markus J.P. Kruesi, Mark E. Schmidt, Maureen Donnelly, Euthymia D. Hibbs, Susan D. Hamburger	1989	66
16	Preclinical Evaluation of¹⁸F-JNJ64349311, a Novel PET Tracer for Tau Imaging Journal of Nuclear Medicine ·Lieven Declercq, Frederik Rombouts, Michel Koole, Katleen Fierens, Jonas Mariën, Xavier Langlois, José Ignacio Andrés, Mark E. Schmidt, Gregor J. Macdonald, Diederik Moechars, Wim Vanduffel, Thomas Tousseyn, Rik Vandenberghe, Koen Van Laere, Alfons Verbruggen, Guy Bormans	2017	65
17	¹⁸F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446 Journal of Nuclear Medicine ·Michel Koole, Mark E. Schmidt, Anja Hijzen, Paulien Ravenstijn, Corinne Vandermeulen, Donatienne Van Weehaeghe, Kim Serdons, Sofie Celen, Guy Bormans, Marc Ceusters, Wei Zhang, Luc Van Nueten, Hartmuth C. Kolb, Jan de Hoon, Koen Van Laere	2018	64
18	A Comparison of Brain and Serum Pharmacokinetics of R-Fluoxetine and Racemic Fluoxetine: A 19-F MRS Study Neuropsychopharmacology ·Michael Henry, Mark E. Schmidt, John Hennen, Rosemond A. Villafuerte, Michelle L. Butman, P. Tran, Lynn T Kerner, Bruce M. Cohen, Perry F. Renshaw	2005	64
19	PET imaging shows loss of striatal PDE10A in patients with Huntington disease Neurology ·Rawaha Ahmad, Sophie Bourgeois, Andrey Postnov, Mark E. Schmidt, Guy Bormans, Koen Van Laere, Wim Vandenberghe	2013	59
20	[11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers European Journal of Nuclear Medicine and Molecular Imaging ·Donatienne Van Weehaeghe, Michel Koole, Mark E. Schmidt, Stephanie Deman, Andreas H. Jacobs, Erika Souche, Kim Serdons, Stefan Sunaert, Guy Bormans, Wim Vandenberghe, Koen Van Laere	2019	58

About Mark E. Schmidt

Mark E. Schmidt is a scholar working on Biological Psychiatry, Psychiatry and Mental health, Behavioral Neuroscience, Radiology, Nuclear Medicine and Imaging and Pharmacology, having authored 126 papers that have together received 4.8k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (28 papers), Alzheimer's disease research and treatments (22 papers), Dementia and Cognitive Impairment Research (19 papers), Treatment of Major Depression (16 papers), Neuroscience and Neuropharmacology Research (15 papers), Functional Brain Connectivity Studies (13 papers), Receptor Mechanisms and Signaling (11 papers) and Bipolar Disorder and Treatment (11 papers). The work is most often cited by research in Biological Psychiatry (290 citations), Psychiatry and Mental health (1.4k citations), Neurology (488 citations), Behavioral Neuroscience (200 citations) and Cellular and Molecular Neuroscience (942 citations). Mark E. Schmidt has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include William J. Jagust, Holly Soares, Leslie M. Shaw, John Q. Trojanowski, John C. Morris, Clifford R. Jack, Robert C. Green, Andrew J. Saykin, Michael W. Weiner and Laurel Beckett. Their work appears in journals such as Alzheimer s & Dementia, Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Neuropsychopharmacology and European Neuropsychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact